Angela Lamarca, Lead of NET HPB and NET Medical Oncologist at Jiménez Díaz Foundation University Hospital and The Christie NHS Foundation Trust , shared a post on X:
“Data on Radionuclide therapy for NETs at ESMO
XT-XTR008-3-01 ( PRRT vs SSA) by DrLiu in previously treated GINETs
Interim analysis PFS – HR 0.06
Subsequent analysis PFS – HR 0.14
- OS not mature
- ORR 55.6% vs 2.1%
- QoL improved.”
More posts about ESMO25.
